Tecentriq (atezolizumab) - Roche
buparlisib (AN2025) - Adlai Nortye
palupiprant (AN0025) - Eisai, Adlai Nortye
http://clinicaltrials.gov/ct2/show/NCT04975958
 
Jun 23, 2025
 
Next